User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 18:05, 18 March 2008 (diff | hist) . . (+218) . . American Arbitration Association (PR & Lobbying) (current)
- 17:59, 18 March 2008 (diff | hist) . . (+4,127) . . N MWW Group (new page)
- 17:31, 18 March 2008 (diff | hist) . . (+142) . . Pharmaceutical Research and Manufacturers of America (→Lobbying and PR firms)
- 17:29, 18 March 2008 (diff | hist) . . (+2) . . m Eli Lilly and Company (→Public Relations, Lobbying and Business Intelligence Firms)
- 17:29, 18 March 2008 (diff | hist) . . (+2) . . m Eli Lilly and Company (→Public Relations, Lobbying and Business Intelligence Firms)
- 16:05, 18 March 2008 (diff | hist) . . (+2,757) . . N McManus Group (new page)
- 15:20, 18 March 2008 (diff | hist) . . (-13) . . User talk:Lynn Hill
- 15:14, 18 March 2008 (diff | hist) . . (+1,241) . . Barbour Griffith and Rogers International (amalgamating pages)
- 16:15, 12 March 2008 (diff | hist) . . (+297) . . User talk:Lynn Hill (note to self)
- 15:48, 12 March 2008 (diff | hist) . . (-1) . . m Pfizer (→PR, Lobbying and Business Intelligence firms)
- 15:48, 12 March 2008 (diff | hist) . . (+16) . . m Pfizer (→PR, Lobbying and Business Intelligence firms)
- 15:45, 12 March 2008 (diff | hist) . . (+167) . . Wyeth (→PR, Lobbying and Market Intelligence firms)
- 15:43, 12 March 2008 (diff | hist) . . (+193) . . Pharmaceutical Research and Manufacturers of America (→Lobbying and PR firms)
- 15:42, 12 March 2008 (diff | hist) . . (+186) . . Coca Cola (→Public Relations and Lobbying)
- 15:40, 12 March 2008 (diff | hist) . . (+2,564) . . N Williams and Jensen (new page)
- 15:18, 12 March 2008 (diff | hist) . . (+2,743) . . N Arnold and Porter (new page)
- 14:17, 12 March 2008 (diff | hist) . . (+193) . . Ogilvy Public Relations Worldwide (subsidiaries)
- 14:16, 12 March 2008 (diff | hist) . . (+1,782) . . N Ogilvy Government Relations (new page)
- 13:57, 12 March 2008 (diff | hist) . . (+1,004) . . N Patton Boggs (new page)
- 13:29, 12 March 2008 (diff | hist) . . (+17) . . Pfizer (→PR, Lobbying and Business Intelligence firms)
- 13:28, 12 March 2008 (diff | hist) . . (+973) . . N Nickles Group (new page)
- 13:16, 12 March 2008 (diff | hist) . . (+951) . . Pfizer (→PR, Lobbying and Business Intelligence firms)
- 12:52, 12 March 2008 (diff | hist) . . (+423) . . GlaxoSmithKline (→Public Relations and Lobbying)
- 12:28, 12 March 2008 (diff | hist) . . (0) . . m Abbott Laboratories (→PR, Lobbying and Market Intelligence firms)
- 12:27, 12 March 2008 (diff | hist) . . (+658) . . Abbott Laboratories (→PR, Lobbying and Market Intelligence firms)
- 11:33, 12 March 2008 (diff | hist) . . (+754) . . Eli Lilly and Company (→Public Relations, Lobbying and Business Intelligence Firms)
- 11:20, 12 March 2008 (diff | hist) . . (+170) . . Eli Lilly and Company (→Government and the Corporate Purse)
- 11:16, 12 March 2008 (diff | hist) . . (+1,485) . . Eli Lilly and Company (→Public Relations, Lobbying and Business Intelligence Firms)
- 17:01, 11 March 2008 (diff | hist) . . (+1,651) . . GlaxoSmithKline (→Public Relations and Lobbying)
- 16:40, 11 March 2008 (diff | hist) . . (+2,530) . . Abbott Laboratories (Government and the Corporate Purse)
- 16:05, 11 March 2008 (diff | hist) . . (+1,018) . . Pfizer (→PR, Lobbying and Business Intelligence firms)
- 15:47, 11 March 2008 (diff | hist) . . (+1,878) . . Pfizer (Government and the Corporate Purse)
- 15:11, 11 March 2008 (diff | hist) . . (-285) . . User talk:Lynn Hill
- 15:10, 11 March 2008 (diff | hist) . . (+257) . . Wyeth (→PR, Lobbying and Market Intelligence firms)
- 15:08, 11 March 2008 (diff | hist) . . (+305) . . Schering-Plough (→Partnerships and Affiliations)
- 15:06, 11 March 2008 (diff | hist) . . (+273) . . Sanofi-Aventis Group (→PR, Lobbying and Business Intelligence firms)
- 14:01, 11 March 2008 (diff | hist) . . (+257) . . Pfizer (→PR, Lobbying and Business Intelligence firms)
- 13:58, 11 March 2008 (diff | hist) . . (+290) . . Novartis (→PR, Lobbying and Business Intelligence firms)
- 13:57, 11 March 2008 (diff | hist) . . (+273) . . Merck KGaA (current)
- 13:56, 11 March 2008 (diff | hist) . . (+258) . . Merck and Co. Inc. (→Public Relations, Lobbying and Business Intelligence Firms)
- 13:53, 11 March 2008 (diff | hist) . . (+257) . . GlaxoSmithKline (→Public Relations and Lobbying)
- 13:52, 11 March 2008 (diff | hist) . . (+266) . . Eli Lilly and Company (→Public Relations, Lobbying and Business Intelligence Firms)
- 13:49, 11 March 2008 (diff | hist) . . (+292) . . Bristol-Myers Squibb (→Affiliations)
- 13:45, 11 March 2008 (diff | hist) . . (+4) . . m Abbott Laboratories (→Affilliations)
- 13:43, 11 March 2008 (diff | hist) . . (-6,247) . . International Federation of Pharmaceutical Manufacturers Associations (current)
- 13:42, 11 March 2008 (diff | hist) . . (+204) . . International Federation of Pharmaceutical Manufacturers and Associations (Individuals)
- 13:34, 11 March 2008 (diff | hist) . . (+3,819) . . International Federation of Pharmaceutical Manufacturers and Associations (→Individuals)
- 13:07, 11 March 2008 (diff | hist) . . (+287) . . Abbott Laboratories (→Affilliations)
- 13:05, 11 March 2008 (diff | hist) . . (+1,204) . . N Brand(X) (new page) (current)
- 12:51, 11 March 2008 (diff | hist) . . (+915) . . Conference Board (→People)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
